HEL conducts workshop on hydrogenation and catalytic processes

HEL, a leading manufacturer of process development and safety systems right from small volume parallel screening, mid-volume optimisation and scale up with technology transfer by automated pilot reactor upto 50 litre, recently conducted a workshop in Mumbai. Around 53 participants from 28 companies took part in the workshop. Major research institutes like BARC and UICT also took part in it.

A half-day presentation on ‘Continuous and batch process development for hydrogenation and other catalytic processes ‘was conducted by Dr Jasbir Singh, Managing Director, HEL.

Dr Dhananjay Sathe, Vice President, Unichem Laboratories, stated that the workshop to be ‘ a good overview and comparison of data with regard to batch and continuous flow process’ and Dr Deepak Satoskar, Head of R&D, Johnson Matthey, mentioned that it ‘was a good workshop on hydrogenation and catalytic reactions’.

HEL has been involved with many customised projects with many companies such as GSK, AstraZeneca, Pfizer, Syngenta, Abott, Teva, Dishman, Watson Pharma, Dr Reddy’s Labs, Cipla, HEMRL, CFEES, Defence Lab, IGCAR, UICT, US Vitamins, Sai Advantium, AptuitLaurus, Alembic, Lupin, Advinus, Shell to name a few of them, for their process developmental activities through automated reactors for different volume, process safety through Reaction Calorimetry, Adiabatic Calorimeter as hazard assessment devices, and various systems for hydrogenation, crystallisation and parallel chemistry. HEL is the supplier of more than 1,000 customised automated reactors for many applications

EP News Bureau